Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose rabeprazole sodium for peptic ulcer bleeding
ChiCTR1800020352Phase 4Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rabeprazole in Peptic ulcer disease (PUD), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Effective hemostasis rate under endoscopy within 72 hours. Planned start Aug 2018; status: not yet recruiting.
02
Drugs
rabeprazole
03
Conditions
Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on ChiCTR1800020352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800020352.